A post by Vivian Cheng at Science Progress chronicles a recent accusation of data-falsification in a study on a bone-growth treatment. Timothy Kuklo, a former Army orthopedic surgeon now at Washington University in St. Louis authored an article in the British Journal of Bone and Joint Surgery that said Medtronic's Infuse was better at treating severe leg injuries suffered by soldiers than traditional therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.